Ashley Rosko MD

Ashley Rosko MD
Asst Professor - ClinicalCollege of
A344 Starling Loving Hall 320 W 10th Avenue Columbus OH 43210
Phone:(614) 688-7937Fax: (614) 293-4812
  • Cancer Control

General Research Interest

myeloma and aging

Research Description

Dr. Rosko’s research aims are to develop an expertise in cancer and aging, advance translational geriatric research efforts, and improve outcomes in older adults with myeloma. Nationally, I am involved with the Cancer and Aging Research Group and have approved in an international investigation of the impact of age and transplant outcomes in ALL patients (EBMT/CIBMTR). Her most recent research proposal focuses on comprehensive frailty assessments paired with biomarkers to predict morbidity and mortality in myeloma patients. Becoming in active member of the OSUCCC will hone leadership skills and will serve as a standard for my professional growth and development.

Current Publications

  • Sborov DW, Nuovo GJ, Stiff A, Mace TA, Lesinski GB, Benson DM, Efebera YA, Rosko AE, Pichiorri F, Grever MR, Hofmeister CCA Phase 1 Trial of Single Agent Reolysin in Patients with Relapsed Multiple Myeloma.Clin Cancer Res in press 10/7/2014
  • Wildes TM, Rosko A, Tuchman SAMultiple myeloma in the older adult: better prospects, more challenges.J Clin Oncol 32 2531-40 8/20/2014
  • Rosko AE, Corriveau M, Suwantarat N, Arfons L, Treasure M, Parker P, Jacobs M, Fu P, Salata R, Lazarus HMVancomycin-resistant enterococci infection: not just for the transplanted.Leuk Lymphoma 55 1320-5 6/1/2014

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: